Search - tctmd.com

Displaying 641 - 660 of 842

Sort: Relevancy | Date

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

November 02, 2014

News Industry News

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

October 13, 2014

News Industry News

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

September 15, 2014

News Industry News

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

September 13, 2014

News Industry News

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

September 12, 2014

News Industry News

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

September 11, 2014

News Industry News

Transcatheter Technologies will report one-year follow-up results for study of its ‘truly repositionable’ Trinity TAVI system at ‘TCT 2014’ in Washington, DC

September 10, 2014

News Industry News

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

September 03, 2014

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Caitlin E. Cox

September 02, 2014

News Daily News

第一代TAVR器械之间的主动脉反流风险和结果不同

Caitlin E. Cox

August 07, 2014

News Daily News

Las Consecuencias del Riesgo de Regurgitación Aórtica Varían entre los Dispositivos TAVR de 1ª Generación

Caitlin E. Cox

August 07, 2014

News Daily News

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Caitlin E. Cox

August 07, 2014

News Daily News

利用CMR技术新发现的TAVR后心肌损伤与左室功能降低有关系

Yael L. Maxwell

July 24, 2014

News Daily News

Una Nueva Lesión Miocárdica Post-TAVR Identificada mediante RMC se asocia a una Menor LVEF

Yael L. Maxwell

July 24, 2014

News Daily News

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Yael L. Maxwell

July 24, 2014

News Industry News

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in(1)

July 22, 2014

News Industry News

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

July 22, 2014

News Industry News

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

July 14, 2014

News Industry News

JENAVALVE ANNOUNCES FIRST IMPLANTATION OF TRANSAPICAL TAVI SYSTEM IN SWEDEN

June 04, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

Advertisement

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

Transcatheter Technologies will report one-year follow-up results for study of its ‘truly repositionable’ Trinity TAVI system at ‘TCT 2014’ in Washington, DC

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

第一代TAVR器械之间的主动脉反流风险和结果不同

Las Consecuencias del Riesgo de Regurgitación Aórtica Varían entre los Dispositivos TAVR de 1ª Generación

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

利用CMR技术新发现的TAVR后心肌损伤与左室功能降低有关系

Una Nueva Lesión Miocárdica Post-TAVR Identificada mediante RMC se asocia a una Menor LVEF

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in(1)

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

JENAVALVE ANNOUNCES FIRST IMPLANTATION OF TRANSAPICAL TAVI SYSTEM IN SWEDEN

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content